International Clinical Trial: Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Immunogenicity Profiles of Single Doses of HCXT-2001 Tablets (A) in Healthy Adult Participants, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (A)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132124) titled 'Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Immunogenicity Profiles of Single Doses of HCXT-2001 Tablets (A) in Healthy Adult Participants, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (A)' on Sept. 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Hospital of Anhui Medical University

Condition: Psoriasis

Intervention: Standard Queues (Queue 1, Queue 2, Queue 4, Queue 5):Administer HCXT-2001 Tablets (A) and HCXT-2001 Tablets (A) placebo

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollmen...